1. Drug helps, doesn’t hurt, lung disease » Respiratory distress syndrome patients treated with a neuromuscular blocker are more likely than those on a placebo to survive 90 days, and show no increase in muscle weakness—a common concern among doctors.
L. Papazian et al., N Engl J Med, 363:1107-16, 2010. Evaluated by A. Benson & I. Douglas, Univ Colorado and Denver Health; M. Gropper, UCSF; R. Basner, Columbia Univ College of Physicians and Surgeons; J. Sellares & A. Torres, Hosp Cln de Barcelona; M. Gama de Abreu, Clinic Carl Gustav Carus; J. Neely & A. Vuylsteke, Papworth Hosp; G. Martin, Emory Univ; M. O’Connor, Univ Chicago; P. Fassbender & M. Eikermann, Mass Gen Hosp. Free F1000 Evaluation
2. Skip the surgery? » A nonsurgical treatment for severe aortic stenosis, a type of heart disease characterized by the narrowing of the aortic valve opening, may provide an alternative for patients who ...
